Radar mondial UDTR

UDTR — Radar mondial des droits de la Nature

Registre documentaire des références détectées à travers les infrastructures académiques, juridiques et institutionnelles surveillées par UDTR.

Une infrastructure documentaire mondiale conçue pour atteindre la couverture la plus large, vérifiable et scientifiquement défendable des droits de la Nature.

← Retour au Radar

Long-term efficacy of sapropterin in phenylketonuria: a systematic review and meta-analysis of blood phenylalanine reduction, dietary tolerance, and patient-related outcomes

Identification

Clé publique
radar:r-7c6bc245db6f90fd4b93f070da6de946
Auteurs
Roberta Leonardi · Manuela Lo Bianco · Annamaria Sapuppo · Concetta Meli · Alessia Migliore · Luisa La Spina · Giuseppina Lanzafame · Maria Grazia Pappalardo · Riccardo Iacobacci · Alessia Arena · Grete Francesca Privitera · Martino Ruggieri · Agata Polizzi · Andrea D. Praticò
Année déclarée
2026
Langue déclarée
en
Type source
review
Première détection
2026-11-13T12:45:48.187438+00:00
Dernière observation des métadonnées
2026-11-13T12:45:48.187438+00:00
Dernière vérification HTTP
Non effectuée

Institutions déclarées par la source

University of Catania · Policlinico Universitario di Catania · Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco" · Università degli Studi di Enna Kore

Pays d’affiliation déclarés

IT

Résumé documentaire — langue originale

Abstract Background Phenylketonuria (PKU) is an inherited metabolic disorder caused by mutations in the phenylalanine hydroxylase (PAH) gene, leading to impaired phenylalanine (Phe) metabolism. The mainstay of treatment is a strict low-Phe diet, which can be burdensome. Sapropterin dihydrochloride (Kuvan ® ), a synthetic form of tetrahydrobiopterin (BH4), offers a pharmacological alternative, potentially improving metabolic control and dietary flexibility. However, treatment response varies, and long-term effects remain uncertain. Objective This systematic review and meta-analysis aimed to evaluate the long-term efficacy of Sapropterin in PKU patients, focusing on blood Phe levels, dietary Phe tolerance, and patient-related outcomes such as BMI and IQ. Methods A comprehensive literature search was conducted in PubMed/MEDLINE and Web of Science, following PRISMA guidelines. Studies were included if they reported long-term outcomes of Sapropterin therapy in PKU, assessing Phe levels, dietary tolerance, or patient-related parameters. Meta-analyses were performed using the Wilcoxon rank sum test and forest plots. Results Nineteen studies met the inclusion criteria, with 85 patients providing baseline Phe data and 54 with post-treatment values. Sapropterin significantly reduced blood Phe levels, especially in classic PKU patients with high baseline levels ( p = 0.025). Effects on dietary Phe tolerance were variable, and meta-analysis results were inconsistent. Limited data on BMI and IQ precluded firm conclusions on growth and neurocognition. Genotype analysis ( n = 70) highlighted frequent PAH variants (e.g., p.L48S, p.R261Q), but genotype–response associations remained unclear. Conclusions Sapropterin effectively lowers blood Phe levels in classic PKU, but further studies with standardized measures are needed to clarify its impact on dietary tolerance, growth, cognition, and genotype-based treatment response.

Identifiants

OPENALEX
https://openalex.org/W7204944807
DOI
10.1186/s13023-026-04553-6

Repères documentaires

Famille documentaire
unknown
Types déclarés par les sources
review
Éditeurs
BioMed Central

Les mentions d’entités ne constituent pas une preuve de reconnaissance juridique. La juridiction étudiée est distincte du pays d’affiliation des auteurs.

Sources

OpenAlex · Document 1

Citer cette référence

Roberta Leonardi; Manuela Lo Bianco; Annamaria Sapuppo; Concetta Meli; Alessia Migliore; Luisa La Spina; Giuseppina Lanzafame; Maria Grazia Pappalardo; Riccardo Iacobacci; Alessia Arena; Grete Francesca Privitera; Martino Ruggieri; Agata Polizzi; Andrea D. Praticò. Long-term efficacy of sapropterin in phenylketonuria: a systematic review and meta-analysis of blood phenylalanine reduction, dietary tolerance, and patient-related outcomes. 2026. https://doi.org/10.1186/s13023-026-04553-6

JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·

APA, Chicago, ISO 690 : formats bibliographiques fondés sur les champs disponibles. OSCOLA / Bluebook : données structurées uniquement ; aucune conformité juridique complète n’est revendiquée sans vérification des éléments nécessaires.

APA
Roberta Leonardi; Manuela Lo Bianco; Annamaria Sapuppo; Concetta Meli; Alessia Migliore; Luisa La Spina; Giuseppina Lanzafame; Maria Grazia Pappalardo; Riccardo Iacobacci; Alessia Arena; Grete Francesca Privitera; Martino Ruggieri; Agata Polizzi; Andrea D. Praticò. (2026). Long-term efficacy of sapropterin in phenylketonuria: a systematic review and meta-analysis of blood phenylalanine reduction, dietary tolerance, and patient-related outcomes. https://doi.org/10.1186/s13023-026-04553-6
Chicago
Roberta Leonardi; Manuela Lo Bianco; Annamaria Sapuppo; Concetta Meli; Alessia Migliore; Luisa La Spina; Giuseppina Lanzafame; Maria Grazia Pappalardo; Riccardo Iacobacci; Alessia Arena; Grete Francesca Privitera; Martino Ruggieri; Agata Polizzi; Andrea D. Praticò. Long-term efficacy of sapropterin in phenylketonuria: a systematic review and meta-analysis of blood phenylalanine reduction, dietary tolerance, and patient-related outcomes. 2026. https://doi.org/10.1186/s13023-026-04553-6
ISO 690
Roberta Leonardi; Manuela Lo Bianco; Annamaria Sapuppo; Concetta Meli; Alessia Migliore; Luisa La Spina; Giuseppina Lanzafame; Maria Grazia Pappalardo; Riccardo Iacobacci; Alessia Arena; Grete Francesca Privitera; Martino Ruggieri; Agata Polizzi; Andrea D. Praticò. Long-term efficacy of sapropterin in phenylketonuria: a systematic review and meta-analysis of blood phenylalanine reduction, dietary tolerance, and patient-related outcomes. 2026. https://doi.org/10.1186/s13023-026-04553-6

Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31

UDTR — Bibliothèque juridique mondiale des droits de la Nature. Long-term efficacy of sapropterin in phenylketonuria: a systematic review and meta-analysis of blood phenylalanine reduction, dietary tolerance, and patient-related outcomes. Notice documentaire: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-7c6bc245db6f90fd4b93f070da6de946/ · Dernière vérification HTTP : non effectuée

Signaler une correction

Données de cette version figée

Dossiers et relations documentaires

Rôles des sources

Source bibliographique / publication d’origine · https://doi.org/10.1186/s13023-026-04553-6

Un lien vers une autorité ne prouve pas à lui seul une affirmation juridique. Les résumés et les textes intégraux restent soumis aux conditions de leur source.

Statut documentaire

Pertinence à examiner

Bibliothèque

Cette identité n’est pas encore intégrée à la Bibliothèque juridique.

UDTR — Bibliothèque juridique mondiale des droits de la Nature